TARGETTI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.462
EU - Europa 1.659
AS - Asia 1.565
SA - Sud America 217
Continente sconosciuto - Info sul continente non disponibili 48
AF - Africa 44
OC - Oceania 16
Totale 6.011
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.374
RU - Federazione Russa 533
SG - Singapore 448
CN - Cina 425
IT - Italia 425
PL - Polonia 196
HK - Hong Kong 186
BR - Brasile 175
VN - Vietnam 162
KR - Corea 130
SE - Svezia 115
IE - Irlanda 96
DE - Germania 67
BD - Bangladesh 53
IN - India 53
FR - Francia 52
CA - Canada 48
FI - Finlandia 46
GB - Regno Unito 36
JO - Giordania 26
NL - Olanda 25
AR - Argentina 21
ID - Indonesia 19
JP - Giappone 19
MX - Messico 17
AU - Australia 15
CH - Svizzera 14
UA - Ucraina 10
ES - Italia 9
MA - Marocco 9
DK - Danimarca 8
IQ - Iraq 7
PK - Pakistan 7
ZA - Sudafrica 7
BJ - Benin 6
NG - Nigeria 6
RO - Romania 6
BE - Belgio 5
PH - Filippine 5
CL - Cile 4
CO - Colombia 4
DO - Repubblica Dominicana 4
EC - Ecuador 4
HN - Honduras 4
JM - Giamaica 4
TR - Turchia 4
LT - Lituania 3
MY - Malesia 3
PE - Perù 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
AT - Austria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GT - Guatemala 2
KE - Kenya 2
LK - Sri Lanka 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
YE - Yemen 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.964
Salva come PNG Salva come JPEG
Città #
Santa Clara 408
Singapore 361
Ashburn 338
Warsaw 186
Hong Kong 164
San Jose 154
Hefei 137
Seoul 128
Dallas 100
North Bergen 100
Dublin 96
Fairfield 86
Chandler 63
Beijing 61
Milan 55
Ho Chi Minh City 54
Council Bluffs 48
Seattle 48
Munich 43
Florence 40
Los Angeles 40
Ann Arbor 39
New York 39
Houston 38
Rome 34
Woodbridge 34
Wilmington 33
Cambridge 31
Buffalo 30
Mumbai 30
Lawrence 29
Altamura 28
Phoenix 27
Hanoi 26
The Dalles 26
Lauterbourg 24
São Paulo 23
Boston 22
Chicago 21
Shanghai 20
Turku 20
Princeton 18
Moscow 17
Scandicci 17
Tokyo 16
Frankfurt am Main 15
Helsinki 15
Melbourne 15
Brooklyn 14
Kent 14
Philadelphia 14
Amersfoort 13
Boardman 13
Jakarta 12
Toronto 12
Atlanta 11
Montreal 11
Bologna 9
Lappeenranta 9
Naples 9
Bengaluru 8
Siena 8
Bern 7
Biên Hòa 7
Brasília 7
Copenhagen 7
Da Nang 7
London 7
Andover 6
Cotonou 6
Figino 6
Fontebuona 6
Medford 6
Mexico City 6
Tianjin 6
Abuja 5
Changsha 5
Hải Dương 5
Orem 5
Padua 5
Paris 5
Rio de Janeiro 5
San Diego 5
St Louis 5
Turin 5
Washington 5
Ancona 4
Avellino 4
Barcelona 4
Barnet 4
Brescia 4
Brussels 4
Cagliari 4
Casablanca 4
Columbus 4
Curitiba 4
Dearborn 4
Dong Ket 4
Lausanne 4
Miami 4
Totale 3.749
Salva come PNG Salva come JPEG
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 501
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 260
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 225
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 221
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 209
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 208
Arrhythmic risk stratification in patients with left ventricular ring-like scar 205
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 204
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 197
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 196
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 191
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 188
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 187
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 184
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 184
Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration 180
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 176
[From loss to prevention: lessons to be learned from juvenile sudden death] 169
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 166
The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs 161
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 161
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 158
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 156
Diagnostic Delay in Arrhythmogenic Cardiomyopathy 155
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 155
Cellular Retrograde Cardiomyoplasty and Relaxin Therapyfor Postischemic Myocardial Repair in a Rat Model 153
Aficamten and Cardiopulmonary Exercise Test Performance 146
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy 146
Comparative analysis of a 4-lead portable smartphone-based versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 141
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 133
Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy 119
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 56
Long-Term Follow-Up Data on Flecainide Use as an Antiarrhythmic in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multicenter Study 45
Evolving Epidemiology of Cardiomyopathies at a National Referral Centre: a 30-Year Longitudinal Study 29
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy 25
Myocardial performance during exercise in hypertrophic cardiomyopathy; pressure volume loops and haemodynamic forces analysis 21
Totale 6.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 7 8 4 6 8 10 6 11 23 38
2022/2023444 30 105 26 9 23 61 61 29 50 8 31 11
2023/2024245 5 20 31 16 25 44 18 43 8 7 12 16
2024/20251.533 56 142 111 205 342 188 38 129 46 42 104 130
2025/20262.564 275 373 330 253 232 83 270 101 198 144 91 214
2026/2027521 263 90 168 0 0 0 0 0 0 0 0 0
Totale 6.011